Second Targeted Therapeutic Approved for Use Based on Tumor Biomarker, Not Tumor Origin
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a new wave of molecularly targeted...
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a new wave of molecularly targeted...